Literature DB >> 1086364

Pulmonary dysfunction in systemic lupus erythematosus without pulmonary symptoms.

T W Chick, R J DeHoratius, B E Skipper, R P Messner.   

Abstract

Pulmonary function was measured in a group of 28 patients with systemic lupus erythematosus (SLE) who were free of pulmonary involvement at the time of the study. When compared with age and sex matched controls, the SLE patients had a pattern of restriction with reduced lung volumes and vital capacity. Diffusing capacity was reduced in proportion to the reduction in lung volume. This is felt to be most compatible with inapparent pleural thickening resulting in impaired lung expansion. There was no evidence of airway obstruction on maximal expiratory flow-volume curves. The effect of cigarette smoking in the SLE patients was a reduction in flows at low lung volumes, which was indistinguishable from the effects in the control smokers. Both SLE and control smokers had a significant reduction in DL/VA when compared with control nonsmokers. Pulmonary function was not influenced by the presence of renal disease.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1086364

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  3 in total

1.  Shrinking lung syndrome as a presenting manifestation of systemic lupus erythematosus in a female Kuwaiti.

Authors:  Haneen Adel Al-Raqum; Sukhbir Singh Uppal; Moudi Al-Mutairy; Rakesh Kumari
Journal:  Clin Rheumatol       Date:  2005-12-23       Impact factor: 2.980

2.  Bronchoalveolar lavage cell analysis and lung function impairment in patients with systemic lupus erythematosus (SLE).

Authors:  H Groen; M Aslander; H Bootsma; T W van der Mark; C G Kallenberg; D S Postma
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

3.  Gas transfer and pulmonary function tests in women with disseminated lupus erythematosus.

Authors:  Babak Amra; Bijan Iraj; Zahra Seyyed Benakdar; Hamid Sanei; Golshan Mohammad
Journal:  ARYA Atheroscler       Date:  2012
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.